加载中
NASDAQHealthcareMedical - Instruments & Supplies
最新数据
US$55.545
+US$1.175 · +2.16%
The Cooper Companies, Inc. (COO) operates as a global medical device firm, primarily focused on developing, producing, and distributing products through two distinct business units: CooperVision and CooperSurgical. CooperVision specializes in contact lenses. Their product range includes spherical lenses for common vision issues like nearsightedness and farsightedness, as well as advanced lenses such as toric for astigmatism, multifocal for presbyopia, and specialized options addressing myopia, dry eyes, and eye fatigue. These vision correction solutions are available across the Americas, Europe, the Middle East, Africa, and the Asia Pacific region. Meanwhile, CooperSurgical is dedicated to women's and family health, providing a wide array of medical devices, fertility treatments, genetic testing, diagnostic tools, and contraceptives to healthcare providers and patients globally. This segment's offerings encompass various surgical and office-based products like PARAGARD (an IUD), uterine manipulators, retractors, and closure devices. It also delivers comprehensive fertility services, including specialized consumables, equipment, embryo services, and preimplantation genetic screening. Established in 1958, The Cooper Companies, Inc. is headquartered in San Ramon, California.
前收盘价
US$55.545
+US$1.175 · +2.16%
盘后
US$55.55
+US$0.005 · +0.01%
10月12日 19:31 ET
盘中时间采用ET。市场数据可能有所延迟。
The Cooper Companies, Inc. (COO) operates as a global medical device firm, primarily focused on developing, producing, and distributing products through two distinct business units: CooperVision and CooperSurgical. CooperVision specializes in contact lenses. Their product range includes spherical lenses for common vision issues like nearsightedness and farsightedness, as well as advanced lenses such as toric for astigmatism, multifocal for presbyopia, and specialized options addressing myopia, dry eyes, and eye fatigue. These vision correction solutions are available across the Americas, Europe, the Middle East, Africa, and the Asia Pacific region. Meanwhile, CooperSurgical is dedicated to women's and family health, providing a wide array of medical devices, fertility treatments, genetic testing, diagnostic tools, and contraceptives to healthcare providers and patients globally. This segment's offerings encompass various surgical and office-based products like PARAGARD (an IUD), uterine manipulators, retractors, and closure devices. It also delivers comprehensive fertility services, including specialized consumables, equipment, embryo services, and preimplantation genetic screening. Established in 1958, The Cooper Companies, Inc. is headquartered in San Ramon, California.
日内区间
当前US$55.545
52周区间
当前US$55.545
盘中时间采用ET。市场数据可能有所延迟。
GoAI 评分
持有
估值
56
合理估值
情绪
59
多空交织
风险
36
中等风险
动量
39
动能减弱
完整 GoAI 研究
继续查看更深入的依据、催化因素和风险。
The Cooper Companies, Inc. (COO) operates as a global medical device firm, primarily focused on developing, producing, and distributing products through two distinct business units: CooperVision and CooperSurgical. CooperVision specializes in contact lenses. Their product range includes spherical lenses for common vision issues like nearsightedness and farsightedness, as well as advanced lenses such as toric for astigmatism, multifocal for presbyopia, and specialized options addressing myopia, dry eyes, and eye fatigue. These vision correction solutions are available across the Americas, Europe, the Middle East, Africa, and the Asia Pacific region. Meanwhile, CooperSurgical is dedicated to women's and family health, providing a wide array of medical devices, fertility treatments, genetic testing, diagnostic tools, and contraceptives to healthcare providers and patients globally. This segment's offerings encompass various surgical and office-based products like PARAGARD (an IUD), uterine manipulators, retractors, and closure devices. It also delivers comprehensive fertility services, including specialized consumables, equipment, embryo services, and preimplantation genetic screening. Established in 1958, The Cooper Companies, Inc. is headquartered in San Ramon, California.
日内区间
当前US$55.545
52周区间
当前US$55.545
盈利能力占已公布营收的百分比。
营收
营业利润
净利润
| 项目（USD） | 2025财年 | 2024财年 | 2023财年 | 2022财年 | 2021财年 |
|---|---|---|---|---|---|
| 营收 | 40.92亿 USD | 38.95亿 USD | 35.93亿 USD | 33.08亿 USD | 29.23亿 USD |
| 销货成本 | 16.1亿 USD | 13亿 USD | 12.35亿 USD | 11.69亿 USD | 9.67亿 USD |
| 毛利 | 24.83亿 USD | 25.96亿 USD | 23.58亿 USD | 21.4亿 USD | 19.56亿 USD |
| 研究与开发 | 1.72亿 USD | 1.55亿 USD | 1.37亿 USD | 1.1亿 USD | 9270万 USD |
| 销售、一般及管理费用 | 16.28亿 USD | 15.34亿 USD | 15.01亿 USD | 13.42亿 USD | 12.11亿 USD |
| 营业费用 | 18亿 USD | 18.9亿 USD | 18.25亿 USD | 16.32亿 USD | 14.5亿 USD |
| 利息支出 | 1亿 USD | 1.14亿 USD | 1.05亿 USD | 5730万 USD | 2310万 USD |
| 折旧和摊销 | 4.23亿 USD | 3.75亿 USD | 3.68亿 USD | 3.46亿 USD | 3.09亿 USD |
| 营业利润 | 6.83亿 USD | 7.06亿 USD | 5.33亿 USD | 5.08亿 USD | 5.06亿 USD |
| 净利润 | 3.75亿 USD | 3.92亿 USD | 2.94亿 USD | 3.86亿 USD | 29.45亿 USD |
公司数据更新于 2026年10月13日。
近期已公布业绩
近期已公布业绩
第三方分析师预期可能变化，并非 GoAI 建议。
| 行动 | 生效日期 | 详情 | 记录日期 | 付款日期 |
|---|---|---|---|---|
股票拆分 | 2024年2月20日 | 4:1 | — | — |
股票拆分 | 2002年11月25日 | 2:1 | — | — |
股票拆分 | 1995年9月22日 | 1:3 | — | — |
股票拆分 | 1983年9月26日 | 11:10 | — | — |
已生效 2024年2月20日
4:1
已生效 2002年11月25日
2:1
已生效 1995年9月22日
1:3
已生效 1983年9月26日
11:10
AI 生成内容及延迟市场数据仅供信息与教育用途，不构成投资建议。
